XML 16 R7.htm IDEA: XBRL DOCUMENT v3.23.3
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2023
Oct. 01, 2022
Sep. 30, 2023
Oct. 01, 2022
Dec. 31, 2022
Operating activities:          
Net loss $ 43,731 $ (206,036) $ (24,120) $ (221,087)  
Adjustments to reconcile net loss to cash (used for) provided by operating activities:          
Depreciation and amortization     39,805 33,371  
Amortization of deferred financing costs and debt discount     3,763 3,763  
Impairment of franchise rights acquired and goodwill   312,741   339,161  
Impairment of intangible and long-lived assets     197 2,088  
Share-based compensation expense     12,838 10,362  
Deferred tax benefit     (7,449) (107,879)  
Allowance for doubtful accounts     407 54  
Reserve for inventory obsolescence     1,897 4,712  
Foreign currency exchange rate (gain) loss     (31) 3,562  
Changes in cash due to:          
Receivables     9,117 (9,760)  
Inventories     9,009 (725)  
Prepaid expenses     (27,301) 17,613 $ 8,878
Accounts payable     1,221 (3,634)  
Accrued liabilities     (17,010) 15,390 20,925
Deferred revenue     309 (3,576)  
Other long term assets and liabilities, net     (2,701) (4,662)  
Income taxes     (1,104) 1,793 4,577
Cash (used for) provided by operating activities     (1,153) 80,546 76,646
Investing activities:          
Capital expenditures     (2,143) (1,756)  
Capitalized software expenditures     (26,190) (27,584)  
Cash paid for acquisitions, net of cash acquired     (38,362) (4,350)  
Other items, net     (14) (29)  
Cash used for investing activities     (66,709) (33,719)  
Financing activities:          
Taxes paid related to net share settlement of equity awards     (1,417) (1,938)  
Proceeds from stock options exercised     710    
Cash paid for acquisitions     (1,178) (113)  
Other items, net     (43) (86)  
Cash used for financing activities     (1,928) (2,137)  
Effect of exchange rate changes on cash and cash equivalents     (1,038) (10,193)  
Net (decrease) increase in cash and cash equivalents     (70,828) 34,497  
Cash and cash equivalents, beginning of period     178,326 153,794 153,794
Cash and cash equivalents, end of period $ 107,498 $ 188,291 $ 107,498 $ 188,291 $ 178,326